Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
Cash flows from operating activities:
Net income	$ 24,456	$ 21,406
Adjustments to reconcile net income to net cash provided by operating activities:
Loss from discontinued operations, net of tax	524	2,459
Gain on sale of operations, net	(2,745)	(376)
Depreciation and amortization expense	9,995	10,213
Amortization of discount on notes and deferred financing costs	2,814	2,572
Bad debt expense, net of recoveries	2,155	2,100
Adjustment to contingent earnout liability	(1,069)	(721)
Deferred income taxes	(4,060)	(961)
Employee stock awards	2,914	2,570
Excess tax benefits from share based payment arrangements	(102)	(65)
Changes in assets and liabilities, net of acquisitions and divestitures:
Restricted cash	260	3,377
Accounts receivable, net	(19,751)	(28,695)
Other assets	1,370	1,944
Accounts payable	(2,040)	4,591
Income taxes payable/refundable	11,220	5,234
Accrued personnel costs and other liabilities	(2,365)	1,855
Net cash provided by continuing operations	23,576	27,503
Operating cash flows used in discontinued operations	(623)	(1,809)
Net cash provided by operating activities	22,953	25,694
Cash flows from investing activities:
Business acquisitions and contingent consideration, net of cash acquired	(10,863)	(28,986)
Purchases of client fund investments	(15,114)	(9,740)
Proceeds from the sales and maturities of client fund investments	9,196	5,000
Proceeds from sales of divested and discontinued operations	694	1,058
Net (increase) decrease in funds held for clients	(12,656)	31,542
Additions to property and equipment, net	(941)	(1,401)
Other	11	13
Net cash used in investing activities	(29,673)	(2,514)
Cash flows from financing activities:
Proceeds from bank debt	277,750	261,025
Payment of bank debt	(247,650)	(256,025)
Repurchase of convertible notes	(39,250)
Payment for acquisition of treasury stock	(648)	(7,602)
Net increase (decrease) in client funds obligations	16,174	(26,802)
Proceeds from exercise of stock options	768	1,144
Payment of contingent consideration of acquisitions	(330)
Excess tax benefit from exercise of stock awards	102	65
Debt issuance costs	(560)	(1,940)
Other	(149)	(83)
Net cash provided by (used in) financing activities	6,207	(30,218)
Net decrease in cash and cash equivalents	(513)	(7,038)
Cash and cash equivalents at beginning of year	724	7,178
Cash and cash equivalents at end of period	$ 211	$ 140